EGFR and cancer: For example, Zhang et al showed that miR‐143 targets epidermal growth factor receptor (EGFR) and suppresses the cell proliferation and invasion of NSCLC in vitro, suggesting miR‐143 as potential therapeutic target against NSCLC.29 Therefore, our study underscored the critical role of miRNAs in cancer and miRNAs other than miR‐33b may also be important regulators of NSCLC.